Thermo Fisher Scientific, the world leader in serving science, and the Centre for Cellular and Molecular Platforms (C-CAMP) recently announced a collaborative initiative to establish a Centre of Excellence in Bengaluru.
This state-of-the-art facility will serve as a hub for fostering innovation, accelerating breakthroughs in the biotechnology sector and enabling researchers to enhance their expertise and achieve their entrepreneurial ambitions.
As a part of this strategic partnership, C-CAMP will provide the necessary infrastructure at their premises to set up the Centre of Excellence. Thermo Fisher will equip the facility with advanced workflow-based solutions in flow cytometry and molecular biology and extend its expertise to offer research and training opportunities to scientists from start-ups under the C-CAMP umbrella, academia, and biopharma and biotech institutes.
Amit Chopra, Managing Director, India & South Asia, Thermo Fisher Scientific said: "India’s bio-economy has consistently witnessed robust double-digit growth over the past decade, projected to reach $300 billion by 2030. The government has been actively fostering an enabling ecosystem to advance biotechnology research, manufacturing and capacity expansion across the country. Additionally, there is a strong emphasis on promoting collaborations between public and private entities and establishing a robust network of bio-incubators and start-ups.”
He further added: “With our industry-leading presence and depth and scale of capabilities, we are committed to supporting the government’s efforts and elevating India’s global standing in the biotechnology domain. Our partnership with C-CAMP reinforces this commitment, and is aimed at driving technological advancements and scientific excellence.”
As a Department of Biotechnology, Government of India, supported initiative C-CAMP is positioned as one of India's premier sciences and technology start-up hubs, engaged in facilitating bioscience research and entrepreneurship. C-CAMP has so far supported more than 400 start-ups, many of whom are pursuing exceptionally innovative research in frontline areas such as drug discovery, cell and gene therapy and biofuels.
Welcoming the move, Dr. Taslimarif Saiyed, Director & CEO, C-CAMP, said: “As a leading technology provider, Thermo Fisher plays a vital role in biosciences research and development. At C-CAMP, we believe in the importance of forging deeper collaborations with companies like Thermo Fisher, to provide access to high-end technology platforms for researchers, innovators and developers.”
“We rely on Thermo Fisher’s extensive portfolio including Attune Flow Cytometer, imaging solutions (EVOS), ultra-low temperature freezers, incubators, centrifuges and sequencers to advance our work in molecular biology, cell biology, flow cytometry, mass spectrometry and genomics. This recent collaboration will further enable innovators, both within and outside of C-CAMP, to access state-of-the-art technical solutions, empowering them to pursue scientific knowledge and build technologies for a better India,” he concluded.
January 8, 2024